Zafgen, Inc. (ZFGN) Insider Dennis D. Kim Acquires 10000 Shares
Zafgen, Inc. (ZFGN) Insider Dennis D. Kim Acquires 10000 Shares
16 Julio, 2017, 05:20
Among 8 analysts covering Zafgen Inc (NASDAQ:ZFGN), 2 have Buy rating, 0 Sell and 6 Hold. Zafgen Inc (NASDAQ:ZFGN) has declined 36.39% since July 14, 2016 and is downtrending. The Company develops therapeutics for patients suffering from obesity and obesity-related disorders. The Company's lead product candidate, Beloranib, is a twice-weekly subcutaneous injection being developed for the treatment of multiple indications, including severe obesity in rare diseases, such as Prader-Willi syndrome and hypothalamic injury-associated obesity (HIAO), including craniopharyngioma-associated obesity.
Zafgen, Inc.is a biopharmaceutical company. Roth Capital began coverage on shares of Zafgen in a research note on Thursday, April 20th.
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company. The stock now has a consensus rating of "Hold" and an average price target of $14.67.
Zafgen, Inc. (NASDAQ:ZFGN) is struggling to gain traction with investors, as evidenced by its 0.65 million shares volume.
The company's consensus rating on Reuter's scale remained unchanged from 3 to 3 during a month. It's now trading about -46.13% below its 52-week high.
07/20/2016 - Zafgen, Inc. was downgraded to " by analysts at FBR Capital Markets. The stock's 50-day moving average price is $3.80 and its 200-day moving average price is $4.11.
Zafgen (NASDAQ:ZFGN) last announced its quarterly earnings results on Tuesday, May 9th. The biopharmaceutical company reported ($0.48) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.43) by $0.05. Equities analysts forecast that Zafgen, Inc. will post ($2.34) earnings per share for the current fiscal year.
ILLEGAL ACTIVITY WARNING: "Zafgen, Inc".
McCain has surgery to remove blood clot
McCain's office said in a statement that on the advice of his doctors, the senator will be recovering in Arizona next week. John McCain , R-Arizona, will be in Arizona next week as Republican senators seek to move their health care bill forward.
ZFGN has been the topic of several research reports. If you are accessing this article on another domain, it was copied illegally and republished in violation of worldwide copyright & trademark laws. The correct version of this article can be read at https://sportsperspectives.com/2017/07/14/zafgen-inc-nasdaqzfgn-lowered-to-hold-at-zacks-investment-research.html.
Zafgen, Inc. (NASDAQ:ZFGN) insider Dennis D. Kim purchased 10,000 shares of the firm's stock in a transaction on Tuesday, July 11th. Following the completion of the purchase, the insider now owns 21,443 shares in the company, valued at approximately $72,691.77. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Institutional investors have recently modified their holdings of the stock. Dimensional Fund Advisors LP boosted its position in Zafgen by 41.5% in the fourth quarter. The shares were purchased at an average cost of $3.39 per share, with a total value of $33,900.00. Candriam Luxembourg S.C.A. boosted its position in shares of Zafgen by 97.2% in the first quarter. Candriam Luxembourg S.C.A. now owns 213,000 shares of the biopharmaceutical company's stock valued at $993,000 after buying an additional 105,000 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its position in shares of Zafgen by 937.6% in the first quarter. Bank of New York Mellon Corp now owns 104,199 shares of the biopharmaceutical company's stock valued at $485,000 after buying an additional 5,794 shares in the last quarter.
Cardinals put Stephen Piscotty on DL
Sierra, 21, made his Major League debut on May 7 in Atlanta earlier this season after being purchased from Single-A Palm Beach. Louis Cardinals placed right fielder Stephen Piscotty on the 10-day disabled list Saturday because of a right groin strain.
On August 21 SunTrust Robinson Humphrey held the company rating at "Buy" and moved down the price target from $21.00 to $16.00. Two equities research analysts have rated the stock with a sell rating and four have issued a hold rating to the stock.
It improved, as 48 investors sold EXPE shares while 150 reduced holdings. 116 funds opened positions while 398 raised stakes. Out of 27 Wall Street analysts rating Dollar Tree Inc ., 16 give it "Buy", 2 "Sell" rating , while 9 recommend "Hold".
Dequalan Dejuan Harris of Cedar Hill has been charged with Obstructing Official Business, Resisting Arrest and Abuse of a Corpse. Saturday morning and asked to check a residence for a woman reported missing from the Cedar Hill, Texas, jurisdiction.
So, with Harden becoming one of the most well-paid Houstonians to date, we checked out things he could buy here with his millions. There have been challenges consummating a deal because of Anthony's contract and forward Ryan Anderson .
Moon inherited an open, export-reliant economy that's fallen into a stagnant-wage funk made worse by record household debt levels. Should they include 59 Tomahawk missiles - mirroring Trump's Syria attack - Moon's options become excruciatingly limited.
Police officers are speaking to a number of witnesses and investigating the incident, Acting Inspector Andrew Mortimore said. Alternatively, information can be left anonymously via the Crimestoppers 0800 555 111 line.
The tourists were rushed to a local hospital, according to officials said who did not disclose their conditions or nationalities. In 2015, an Islamic State affiliate in Egypt downed a Russian plane over Sinai, killing all 224 passengers aboard.
Las autoridades "solo dan evasivas, ningún avance, lo que estamos viendo es que ellos solo quieren ganar tiempo y dejar esto impune".
Manpowergroup Inc (NYSE:MAN) Quarterly Sentiment Report
Parametrica Management Ltd bought a new position in shares of ManpowerGroup during the first quarter worth approximately $201,000. The institutional investors in our partner's database reported: 58.59 million shares, down from 59.71 million shares in 2016Q3.
Revised Senate bill fails to address core AMA concerns
Mark Warner (D) introduced three proposals Wednesday aimed at improving the Affordable Care Act (ACA ), also known as Obamacare. Senators must "do no harm" by scrapping the destructive BCRA and starting over with a bipartisan bill that puts patients first.
Wimbledon men's final talking points
Men's doubles final: No. 4 Lukasz Kubot and Marcelo Melo beat No. 16 Oliver Marach and Mate Pavic 5-7, 7-5, 7-6 (2), 3-6, 13-11. The winner of tomorrow's final will receive £2.2 million ($2.8 million), which could cover quite a lot of physiotherapy.
Steel Dynamics, Inc. (STLD) Releases Q2 Earnings Guidance
The Company's divisions include steel operations, metals recycling operations, steel fabrication activities and Other Operations. Americafirst Capital Management LLC purchased a new stake in shares of Steel Dynamics during the first quarter worth $337,000.